当前位置: 首页 > 期刊 > 《上海医药》 > 2022年第1期
编号:52338
精神运动康复疗法结合舍曲林治疗抑郁障碍的疗效与安全性研究
http://www.100md.com 2022年1月23日 2022年第1期
     张慧 姚慧慧 谢远丝

    摘 要 目的:探讨精神运动康复结合舍曲林治疗抑郁障碍的疗效与安全性。方法:将80例抑郁障碍患者按入组的先后顺序分为对照组(舍曲林50~200 mg/d)和研究组(舍曲林50~200 mg/d+精神运动康复治疗)各40例。治疗8周后,对比两组的临床疗效和安全性。结果:两组患者治疗后各时间点的汉密尔顿抑郁量表(Hamilton’s depression scale, HAMD)评分均较治疗前降低,研究组评分低于对照组(P<0.05);研究组最终临床疗效优于对照组(P<0.05)。两组治疗后各时间点不良反应量表(treatment emergent symptom scale, TESS)评分均无明显差异(P>0.05)。结论:精神运动康复结合舍曲林治疗抑郁障碍疗效显著,安全性高。

    关键词 精神运动康复 舍曲林 抑郁障碍 疗效 安全性

    中图分类号:R749.059; R749.92 文献标志码:B 文章编号:1006-1533(2022)01-0031-03

    基金项目:2019年东莞市社会科技发展一般项目(201950715006338)

    Efficacy and safety of psychomotor rehabilitation combined with sertraline in the treatment of depressive disorder

    ZHANG Hui, YAO Huihui, XIE Yuansi

    (Dongguan Mental Health Center, Dongguan 523016, China)

    ABSTRACT Objective: To investigate the efficacy and safety of psychomotor rehabilitation combined with sertraline in the treatment of depressive disorder. Methods: Eighty patients with depression were divided into a control group (sertraline 50-200 mg/d) and a study group (sertraline 50-200 mg/d plus psychomotor rehabilitation). Clinical efficacy and safety were compared between the two groups after 8 weeks of treatment. Results: The scores of Hamilton’s depression scale (HAMD) in both groups were lower after treatment than before and furthermore were lower in the study group than the control group (P<0.05) ......

您现在查看是摘要页,全文长 9387 字符